Impaired metabolism-secretion coupling in pancreatic β-cells: Role of determinants of mitochondrial ATP production

Diabetes Research and Clinical Practice

Volumn 77, Issue 3 SUPPL., 2007, Pages

  Fujimoto, Shimpei ^a   Nabe, Koichiro ^a   Takehiro, Mihoko ^a   Shimodahira, Makiko ^a   Kajikawa, Mariko ^a   Takeda, Tomomi ^a   Mukai, Eri ^a   Inagaki, Nobuya ^a   Seino, Yutaka ^b  

^a KYOTO UNIVERSITY   (Japan)

^b KANSAI DENRYOKU HOSPITAL   (Japan)

Author keywords

ATP; Glucose metabolism; Impaired insulin secretion; Mitochondria; Pancreatic cell

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; CALCINEURIN; FATTY ACID; GLUCOKINASE; GLUCOSE; INSULIN; ISOCITRATE DEHYDROGENASE; KETONE BODY; MALATE DEHYDROGENASE; NITRIC OXIDE; OUABAIN; PHENYTOIN; POTASSIUM CHANNEL; PYRUVATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TACROLIMUS; TRANSCRIPTION FACTOR NFAT; UNCOUPLING PROTEIN 2; VOLTAGE GATED CALCIUM CHANNEL;

ALKALINIZATION; ARTICLE; CELL MEMBRANE POTENTIAL; CITRIC ACID CYCLE; CYTOSOL; EXOCYTOSIS; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; HYPERPOLARIZATION; IMPAIRED INSULIN SECRETION; INSULIN RELEASE; KETOACIDOSIS; MITOCHONDRION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PANCREAS ISLET BETA CELL; PROTON MOTIVE FORCE; RESPIRATORY CHAIN;

ADENOSINE TRIPHOSPHATE; GLUCOSE; HUMANS; INSULIN-SECRETING CELLS; MITOCHONDRIA; MODELS, BIOLOGICAL; REACTIVE OXYGEN SPECIES;

EID: 34547699225     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.01.026     Document Type: Article

References (80)

1. Henquin J.C. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49 (2000) 1751-1760
2. Prentki M., Tornheim K., and Corkey B.E. Signal transduction mechanisms in nutrient-induced insulin secretion. Diabetologia 40 (1997) S32-S41
3. Maechler P., and Wollheim C.B. Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis. Nature 402 (1999) 685-989
4. Rorsman P. The pancreatic beta-cell as a fuel sensor: an electrophysiologist's viewpoint. Diabetologia 40 (1997) 487-495
5. 2+-dependent exocytosis in pancreatic beta-cells. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 760-765
6. Fujimoto S., Mukai E., Hamamoto Y., Takeda T., Takehiro M., Yamada Y., et al. Prior exposure to high glucose augments depolarization-induced insulin release by mitigating the decline of ATP level in rat islets. Endocrinology 143 (2002) 213-221
7. Kennedy E.D., Maechler P., and Wollheim C.B. Effects of depletion of mitochondrial DNA in metabolism secretion coupling in INS-1 cells. Diabetes 47 (1998) 374-380
8. Tsuruzoe K., Araki E., Furukawa N., Shirotani T., Matsumoto K., Kaneko K., et al. Creation and characterization of a mitochondrial DNA-depleted pancreatic β-cell line: impaired insulin secretion induced by glucose, leucine, and sulfonylureas. Diabetes 47 (1998) 621-631
9. Meglasson M.D., and Matschinsky F.M. Pancreatic islet glucose metabolism and regulation of insulin secretion. Diab. Metab. Rev. 2 (1986) 163-214
10. Froguel P., Vaxillaire M., Sun F., Velho G., Zouali H., Butel M.O., et al. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 356 (1992) 162-164
11. Kroncke K.D., Kolb-Bachofen V., Berschick B., Burkart V., and Kolb H. Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochem. Biophys. Res. Commun. 175 (1991) 752-758
12. G-monomethyl-l-arginine. FEBS Lett. 299 (1992) 103-106
13. Ankarcrona M., Dypbukt J.M., Brune B., and Nicotera P. Interleukin-1β-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp. Cell Res. 213 (1994) 172-177
14. Beggs M., Beresford G., Clarke J., Mertz R., Espinal J., and Hammonds P. Interleukin-1β inhibits glucokinase activity in clonal HIT-T15 beta-cells. FEBS Lett. 267 (1990) 217-220
15. + channels through suppression of phosphofructokinase activity and inhibits glucose-induced insulin release in pancreatic beta cells. J. Gen. Physiol. 104 (1994) 1079-1098
16. Welsh N., Eizirik D.L., Bendtzen K., and Sandler S. Interleukin-1β-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 129 (1991) 3167-3173
17. Takeda T., Tsuura Y., Fujita J., Fujimoto S., Mukai E., Kajikawa M., et al. Heat shock restores insulin secretion after injury by nitric oxide by maintaining glucokinase activity in rat islets. Biochem. Biophys. Res. Commun. 284 (2001) 20-25
18. Hirano Y., Fujihira S., Ohara K., Katsuki S., and Noguchi H. Morphological and functional changes of islets of Langerhans in FK506-treated rats. Transplantation 53 (1992) 889-894
19. Redmon J.B., Olson L.K., Armstrong M.B., Greene M.J., and Robertson P.R. Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. J. Clin. Invest. 98 (1996) 2786-2793
20. 2+-responsive pathway involving calcineurin and nuclear factor of activated T cells. Mol. Endocrinol. 15 (2001) 1758-1767
21. Radu R.G., Fujimoto S., Mukai E., Takehiro M., Shimono D., Nabe K., et al. Tacrolimus suppresses glucose-induced insulin release from pancreatic islets by reducing glucokinase activity. Am. J. Physiol. 288 (2005) E372-E380
22. MacDonald M.J. High content of mitochondrial glycerol-3-phosphate dehydrogenase in pancreatic islets and its inhibition by diazoxide. J. Biol. Chem. 256 (1981) 8287-8290
23. MacDonald M.J. Evidence for the malate aspartate shuttle in pancreatic islets. Arch. Biochem. Biophys. 213 (1982) 643-649
24. Malaisse W.J. Metabolic signaling of insulin secretion. Diab. Rev. 4 (1996) 145-159
25. Solomon S.S., Ensinck J.W., and Williams R.H. Effect of starvation on plasma immunoreactive insulin and non-suppressible insulin-like activity in normal and obese humans. Metabolism 17 (1968) 528-534
26. Tanaka K., Moriya T., Kanamori A., and Yajima Y. Analysis and a long-term follow up of ketosis-onset Japanese NIDDM patients. Diab. Res. Clin. Pract. 44 (1999) 137-146
27. Goberna R., Tamarit Jr. J., Osorio J., Fussganger R., Tamarit J., and Pfeiffer E.F. Action of B-hydroxy butyrate, acetoacetate and palmitate on the insulin release in the perfused isolated rat pancreas. Horm. Metab. Res. 6 (1974) 256-260
28. 86Rb handling and metabolic data. Am. J. Physiol. 259 (1990) E123-E130
29. Zhou Y.P., and Grill V. Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans. J. Clin. Endocrinol. Metab. 80 (1995) 1584-1590
30. Takehiro M., Fujimoto S., Shimodahira M., Shimono D., Mukai E., Nabe K., et al. Chronic exposure to β-hydroxybutyrate inhibits glucose-induced insulin release from pancreatic islets by decreasing NADH contents. Am. J. Physiol. 288 (2005) E365-E371
31. Malaisse W.J., Malaisse-Lagae F., and Sener A. The stimulus-secretion coupling of glucose-induced insulin release: effect of aminooxyacetate upon nutrient-stimulated insulin secretion. Endocrinology 111 (1982) 392-397
32. Eto K., Tsubamoto Y., Terauchi Y., Sugiyama T., Kishimoto T., Takahashi N., et al. Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion. Science 283 (1999) 981-985
33. Leahy J.L., Bonner-Weir S., and Weir G.C. Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion. Diab. Care 15 (1992) 442-455
34. Kimura K., Toyota T., Kakizaki M., Kudo M., Takebe K., and Goto Y. Impaired insulin secretion in the spontaneous diabetes rats. Tohoku J. Exp. Med. 137 (1982) 453-459
35. Portha B., Serradas P., Bailbe D., Suzuki K., Goto Y., and Giroix M.H. β-Cell insensitivity to glucose in the GK rat, a spontaneous nonobese model for type II diabetes. Diabetes 40 (1991) 486-491
36. + channels is impaired in β-cells of the GK rat. A new genetic model of NIDDM. Diabetes 42 (1993) 1446-1453
37. Hughes S.J., Faehling M., Thorneley C.W., Proks P., Ashcroft F.M., and Smith P.A. Electrophysiological and metabolic characterization of single β-cells and islets from diabetic GK rats. Diabetes 47 (1998) 73-81
38. Anello M., Lupi R., Spampinato D., Piro S., Masini M., Boggi U., et al. Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients. Diabetologia 48 (2005) 282-289
39. + channels of pancreatic beta cells in GK rats. Diabetologia (1994) 1082-1087
40. Östenson C.G., Abdel-Halim S.M., Rasschaert J., Malaisse-Lagae F., Meuris S., Sener A., et al. Deficient activity of FAD-linked glycerophosphate dehydrogenase in islets of GK rats. Diabetologia 36 (1993) 722-726
41. Fernandez-Alvarez J., Conget I., Rasschaert J., Sener A., Gomis R., and Malaisse W.J. Enzymatic, metabolic and secretory patterns in human islets of type 2 (non-insulin-dependent) diabetic patients. Diabetologia 37 (1994) 177-181
42. MacDonald M.J., Efendic S., and Östenson C.G. Normalization by insulin treatment of low mitochondrial glycerol phosphate dehydrogenase and pyruvate carboxylase in pancreatic islets of the GK rat. Diabetes 45 (1996) 886-890
43. Ueda K., Tanizawa Y., Ishihara H., Kizuki N., Ohta Y., Matsutani A., et al. Overexpression of mitochondrial FAD-linked glycerol-3-phosphate dehydrogenase does not correct glucose-stimulated insulin secretion from diabetic GK rat pancreatic islets. Diabetologia 41 (1998) 649-653
44. Ling Z.C., Efendic S., Wibom R., Abdel-Halim S.M., Östenson C.G., Landau B.R., et al. Glucose metabolism in Goto-Kakizaki rat islets. Endocrinology 139 (1998) 2670-2675
45. Östenson C.G., Khan A., Abdel-Halim S.M., Guenifi A., Suzuki K., Goto Y., et al. Abnormal insulin secretion and glucose metabolism in pancreatic islets from the spontaneously diabetic GK rat. Diabetologia 36 (1993) 3-8
46. Giroix M.H., Vesco L., and Portha B. Functional and metabolic perturbations in isolated pancreatic islets from the GK rat, a genetic model of noninsulin-dependent diabetes. Endocrinology 132 (1993) 815-822
47. Malherbe C., Burrill K.C., Levin S.R., Karam J.H., and Forsham P.H. Effect of diphenylhydantoin on insulin secretion in man. N. Engl. J. Med. 286 (1972) 339-342
48. Goldberg E.M., and Sanbar S.S. Hyperglycemic, nonketotic coma following administration of Dilantin (Diphenylhydantoin). Diabetes 18 (1969) 101-106
49. Hofeldt F.D., Dippe S.E., Levin S.R., Karam J.H., Blum M.R., and Forsham P.H. Effects of diphenylhydantoin upon glucose-induced insulin secretion in three patients with insulinoma. Diabetes 23 (1974) 192-198
50. Pelkonen R., and Taskinen M.R. Effect of diphenylhydantoin on plasma-insulin in insulinoma. Lancet 1 7803 (1973) 604-605
51. Kizer J.S., Vargas-Gordon M., Brendel K., and Bressler R. The in vitro inhibition of insulin secretion by diphenylhydantoin. J. Clin. Invest. 49 (1970) 1942-1948
52. + concentration in pancreatic islets. Endocrinology 147 (2006) 2717-2727
53. Gunawardana S.C., and Sharp G.W. Intracellular pH plays a critical role in glucose-induced time-dependent potentiation of insulin release in rat islets. Diabetes 51 (2002) 105-113
54. Best L., Yates A.P., Gordon C., and Tomlinson S. Modulation by cytosolic pH of calcium and rubidium fluxes in rat pancreatic islets. Biochem. Pharmacol. 37 (1988) 4611-4615
55. + exchange, an effect not dependent on protein kinase C. J. Biol. Chem. 266 (1991) 23537-23541
56. Misler S., Barnett D.W., Gillis K.D., and Pressel D.M. Electrophysiology of stimulus-secretion coupling in human β-cells. Diabetes 41 (1992) 1221-1228
57. Juntti-Berggren L., Rorsman P., Siffert W., and Berggren P.O. Intracellular pH and the stimulus-secretion coupling in insulin-producing RINm5F cells. Biochem. J. 287 (1992) 59-66
58. Pace C.S., and Goldsmith K.T. Effect of substitution of a permeable weak acid for the permissive role of glucose in amino acid-induced electrical activity in B-cells. Endocrinology 119 (1986) 2433-2438
59. + channel by intracellular pH in B cells of the pancreatic islet. J. Membr. Biol. 109 (1989) 135-143
60. + channels in mouse pancreatic β-cells. J. Physiol. 475 (1994) 33-44
61. + fluxes in isolated islets. Pflügers Arch. 373 (1978) 237-242
62. Tsuura Y., Ishida H., Nishimura M., Fujimoto S., Kajikawa M., and Seino Y. Ouabain suppresses ATP elevation in response to fuel secretagogues in pancreatic islets. Biochem. Biophys. Res. Commun. 249 (1998) 853-857
63. Tsuura Y., Fujimoto S., Kajikawa M., Ishida H., and Seino Y. Regulation of intracellular ATP concentration under conditions of reduced ATP consumption in pancreatic islets. Biochem. Biophys. Res. Commun. 261 (1999) 439-444
64. Kajikawa M., Fujimoto S., Tsuura Y., Mukai E., Takeda T., Hamamoto Y., et al. Ouabain suppresses glucose-induced mitochondrial ATP production and insulin release by generating reactive oxygen species in pancreatic islets. Diabetes 51 (2002) 2522-2529
65. Meachler P., Jornot L., and Wollheim C.B. Hydrogen peroxide alters mitochondrial activation and insulin secretion in pancreatic beta cells. J. Biol. Chem. 274 (1999) 27905-27913
66. 2 with stimulus-secretion coupling in mouse pancreatic β-cells. J. Physiol. 514 (1999) 471-481
67. +-ATPase. J. Biol. Chem. 275 (2000) 27832-27837
68. +-ATPase to ERK 1/2. J. Biol. Chem. 276 (2001) 42050-42056
69. Bindokas V.P., Kuznetsov A., Sreenan S., Polonsky K.S., Roe M.W., and Philipson L.H. Visualizing superoxide production in normal and diabetic rat islets of Langerhans. J. Biol. Chem. 278 (2003) 9796-9801
70. Sakai K., Matsumoto K., Nishikawa T., Suefuji M., Nakamaru K., Hirashima Y., et al. Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic β-cells. Biochem. Biophys. Res. Commun. 300 (2003) 216-222
71. Fridlyand L.E., and Philipson L.H. Does the glucose-dependent insulin secretion mechanism itself cause oxidative stress in pancreatic β-cells?. Diabetes 53 (2004) 1942-1948
72. Carlsson C., Borg L.A., and Welsh N. Sodium palmitate induces partial mitochondrial uncoupling and reactive oxygen species in rat pancreatic islets in vitro. Endocrinology 140 (1999) 3422-3428
73. Koshkin V., Wang X., Scherer P.E., Chan C.B., and Wheeler M.B. Mitochondrial functional state in clonal pancreatic beta-cells exposed to free fatty acids. J. Biol. Chem. 278 (2003) 19709-19715
74. Krauss S., Zhang C.Y., Scorrano L., Dalgaard L.T., St-Pierre J., Grey S.T., et al. Superoxide-mediated activation of uncoupling protein 2 causes pancreatic β cell dysfunction. J. Clin. Invest. 112 (2003) 1831-1842
75. Moore P.C., Ugas M.A., Hagman D.K., Parazzoli S.D., and Poitout V. Evidence against the involvement of oxidative stress in fatty acid inhibition of insulin secretion. Diabetes 53 (2004) 2610-2616
76. Lameloise N., Muzzin P., Prentki M., and Assimacopoulos-Jeannet F. Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-induced insulin secretion?. Diabetes 50 (2001) 803-809
77. Patane G., Anello M., Piro S., Vigneri R., Purrello F., and Rabuazzo A.M. Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-γ inhibition. Diabetes 51 (2002) 2749-2756
78. Joseph J.W., Koshkin V., Saleh M.C., Sivitz W.I., Zhang C.Y., Lowell B.B., et al. Free fatty acid-induced β-cell defects are dependent on uncoupling protein 2 expression. J. Biol. Chem. 279 (2004) 51049-51056
79. Segall L., Lameloise N., Assimacopoulos-Jeannet F., Roche E., Corkey P., Thumelin S., et al. Lipid rather than glucose metabolism is implicated in altered insulin secretion caused by oleate in INS-1 cells. Am. J. Physiol. 277 (1999) E521-E528
80. Poitout V. β-cell lipotoxicity: burning fat into heat?. Endocrinology 145 (2004) 3563-3565